Literature DB >> 8218069

Recent evaluation of prognostic risk factors in esophageal atresia--a multicenter review of 223 cases.

A M Rokitansky1, V A Kolankaya, S Seidl, J Mayr, B Bichler, W Schreiner, M Engels, E Horcher, A Lischka, G Menardi.   

Abstract

In this study, 223 cases of esophageal atresia (Type IIIb: 85.7%; Type II: 5.8%; Type IIIc: 4.0%; Type IIIa: 2.2%; Type IV: 2.2%) from 6 pediatric surgery centers of Austria, were retrospectively examined for the following parameters and their influence on the prognosis: Birth weight (2494.7 +/- 702.0 g), gestation week (range 27-42 weeks; mean 37.3 +/- 3.1 weeks), sex (male: n = 128; female: n = 95), long-gap atresia (> or = 2 cm: n = 33), Tracheomalacia (n = 16), associated malformations (n = 122; cardiac 27.4%, renal 17.9%, skeletal 17.0%, anal: 10.3%, intestinal 9.9%, mediastinal 7.6%, chromosomal 2.2%), preoperative aspiration (n = 92), pneumonia (n = 96), anastomotic insufficiency (n = 45), empyema (n = 5), mediastinitis (n = 8), sepsis (n = 32), other medical complications (n = 122, in 80 infants), other surgical complications (n = 57). The mortality rate was 41.3% overall, from 1975 to 1991; however, it was 25% from 1987 to 1991 and 0% in 1991. A statistically significant correlation was found between prognosis and the following factors: Cardiac malformations (p = 0.0001), medical complications except aspiration and pneumonia (p = 0.0001), empyema (p = 0.0081), mediastinitis (p = 0.0214), and sepsis (p = 0.0295). These 5 significant factors were given different points and a prognostic score was calculated by the addition of these points. This score was predictive for survival in 90.6% of cases and for mortality in 94% of cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8218069     DOI: 10.1055/s-2008-1063542

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Prognostic factors for mortality of oesophageal atresia patients: Waterston revived.

Authors:  Jacqueline A Deurloo; Rien de Vos; Seine Ekkelkamp; Hugo A Heij; Daniel C Aronson
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

2.  Mortality and morbidity in oesophageal atresia.

Authors:  Robert T Peters; Hany Ragab; Malachy O Columb; James Bruce; Ralph J MacKinnon; Ross J Craigie
Journal:  Pediatr Surg Int       Date:  2017-07-12       Impact factor: 1.827

Review 3.  Regenerative Medicine Strategies for Esophageal Repair.

Authors:  Ricardo Londono; Stephen F Badylak
Journal:  Tissue Eng Part B Rev       Date:  2015-04-30       Impact factor: 6.389

4.  Outcome in neonates with esophageal atresia treated over the last 20 years.

Authors:  Helene Engstrand Lilja; Tomas Wester
Journal:  Pediatr Surg Int       Date:  2008-03-20       Impact factor: 1.827

Review 5.  Advances in the treatment of oesophageal atresia over three decades: the 1970s and the 1990s.

Authors:  Jillian Orford; Daniel T Cass; Martin J Glasson
Journal:  Pediatr Surg Int       Date:  2004-05-18       Impact factor: 1.827

6.  Adults with corrected oesophageal atresia: is oesophageal function associated with complaints and/or quality of life?

Authors:  J A Deurloo; E C Klinkenberg; S Ekkelkamp; H A Heij; D C Aronson
Journal:  Pediatr Surg Int       Date:  2008-03-20       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.